Results 301 to 310 of about 180,947 (337)
Tissue-specific and circulatory immune signatures of mucosal inflammation in Crohn’s disease
Ramirez-Navarro L +19 more
europepmc +1 more source
The Potential of High-Density Lipoprotein as a Predictive Biomarker for Infliximab Efficacy in Crohn's Disease. [PDF]
Tang K +6 more
europepmc +1 more source
Pharmacological management of upper gastrointestinal Crohn's disease: a systematic review. [PDF]
Chatto M +11 more
europepmc +1 more source
Luteolin alleviates DSS‐induced ulcerative colitis in mice by targeting the NLRP3 inflammasome, as it shows no effect in NLRP3‐/‐ mice. It inhibits NLRP3 activation and IL‐1β secretion in macrophages by reducing ROS, mtROS and calcium levels via AMPK binding and signalling. Metabolomic changes suggest lipid metabolism involvement. Luteolin represents a
Lianxiang Luo +8 more
wiley +1 more source
Our study demonstrated that TGF‐β1 activated MAPK signalling pathway and promoted the MMT and secretion of CCL17 under CD‐associated intestinal inflammatory conditions. AMSC‐sEVs can deliver MFGE8, which inhibits MMT and CCL17‐mediated Treg recruitment by suppressing the MAPK signalling pathway, thereby alleviating intestinal fibrosis.
Minghao Xie +6 more
wiley +1 more source
An unforgettable diagnostic journey: multimodal evaluation of jejunal diverticulitis mimicking Crohn's disease. [PDF]
Abdulrasak M +5 more
europepmc +1 more source
Cutaneous non‐tuberculous mycobacterial infections: A retrospective study of 94 cases from Germany
Summary Background Cutaneous non‐tuberculous mycobacterial infections (NTM) remain a diagnostic and therapeutic challenge. The aim of this study was to characterize cutaneous NTM infections in Germany over a 24‐year‐period. Patients and Methods 73 patients with cutaneous NTM infections diagnosed at 17 different German University Hospitals from 2000 ...
Luisa Bopp +6 more
wiley +1 more source
Risk Factors for Chronic Kidney Disease in Patients With Crohn's Disease. [PDF]
Rodriguez A +6 more
europepmc +1 more source

